AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat
Go back to AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat| AbbVie (NYSE: ABBV) | Delayed: 249.37 +0.59 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.78 | 52 Week High | $68.12 | |||
| Open | $247.73 | 52 Week Low | $50.71 | |||
| Day High | $250.96 | P/E | 54.09 | |||
| Day Low | $246.77 | EPS | $4.61 | |||
| Volume | 1,221,949 | |||||

